Gilead Sciences to Present at Two Upcoming Investor Conferences

- 15th Annual BIO CEO & Investor Conference on February 12th -

- Leerink Swann Global Healthcare Conference 2013 on February 13th -

- Webcasts Available Through Gilead Corporate Website -

Leerink Swann Global Heathcare Conference
BIO CEO & Investor Conference 2013

FOSTER CITY, Calif.--()--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the BIO CEO & Investor Conference and the Leerink Swann Global Healthcare Conference 2013, both taking place in New York.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company at the BIO conference on Tuesday, February 12 at 11:00 a.m. Eastern Time (ET) and the Leerink Swann conference on Wednesday, February 13 at 10:30 a.m. ET.

To access the live webcasts or replays via the internet log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations

Sharing

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations